Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Primary Hyperoxaluria Mutation Genotyping

This study has been completed.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Oxalosis and Hyperoxaluria Foundation (OHF)
Information provided by (Responsible Party):
Dawn S. Milliner, M.D., Mayo Clinic Identifier:
First received: December 28, 2007
Last updated: July 5, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)